Physician profile
Lori B Lerner
NPI 1811001738
$49,311.33
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2022: $1,947 · 2023: $12K · 2024: $12K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,250 · Travel and Lodging: $1,235 · Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,073.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,250.00 |
| Travel and Lodging | $1,235.23 |
| Food and Beverage | $1,036.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,821.90 | 2023-2025 | Spaceoar Vue System - 10ml, General - Bph, Spaceoar System |
| Neotract INC. | $11,494.07 | 2019 | |
| Sumitomo Pharma America, INC. | $8,280.58 | 2024 | Gemtesa |
| Ambu A/S | $7,413.68 | 2023-2024 | |
| Gyrus Acmi, INC. | $2,500.00 | 2025 | Soltive |
| Procept Biorobotics Corporation | $2,309.88 | 2019-2025 | Aquabeam System |
| Janssen Research & Development, LLC | $1,946.97 | 2022 | |
| Merck Sharp & Dohme LLC | $1,750.00 | 2024-2025 | |
| Ambu INC. | $525.00 | 2024 | |
| Teleflex LLC | $167.35 | 2024 | Urolift |
| Coloplast Corp | $74.82 | 2023 | Titan |
| Olympus America INC. | $27.08 | 2024 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.